CELLCENTRIC LIMITED

Active Cambridge

Research and experimental development on biotechnology

19 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
C

CELLCENTRIC LIMITED

Research and experimental development on biotechnology

Founded 30 Oct 2003 Active Cambridge, United Kingdom 19 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 2 Oct 2025 Next due 30 Sept 2026 3 months remaining
Confirmation
Net assets £38M £37M 2024 year on year
Total assets £41M £16M 2024 year on year
Total Liabilities £3M £21M 2024 year on year
Charges 6
6 satisfied

Contact & Details

Contact

Registered Address

Chesterford Research Park Little Chesterford Cambridge CB10 1XL

Telephone

0800 000 0000

Website

www.example.com

Full company profile for CELLCENTRIC LIMITED (04948632), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 30 Oct 2003. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2015–2024)

Cash in Bank

£38.42M

Increased by £14.49M (+61%)

Net Assets

£37.72M

Increased by £36.94M (+4784%)

Total Liabilities

£3.33M

Decreased by £21.33M (-86%)

Turnover

N/A

Employees

19

Decreased by 1 (-5%)

Debt Ratio

8%

Decreased by 89 (-92%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 8

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 3Jan 2022Series C, Strategic Investment
Investor 4Jul 2024Series C, Strategic Investment
Investor 5Jul 2024Strategic Investment

Share Capital

Share Capital

Share allotments and capital structure

38 Allotments 80,965,843 Shares £171.83m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
1 Dec 202550,000£50£0.001
3 Oct 20252,772,000£3k£0.001
3 Oct 20252,772,000£3k£0.001
22 Apr 202513,389,225£47.04m£3.513
23 Oct 20241,680,000£2k£0.001

Officers

Officers

1 active 2 resigned
Status
Smith, LauraDirectorAmericanUnited States4011 Jul 2024Active

Shareholders

Shareholders (54)

Morningside Venture Investments Ltd
76.5%
39,761,177
Providence Investment Company Limited
6.9%
3,595,806

Persons with Significant Control

Persons with Significant Control (2)

2 Active 2 Ceased

Yuk Lan Wong

Hong Konger

Active
Notified 15 Jan 2020
Residence Hong Kong
DOB March 1967
Nature of Control
  • Significant Influence Or Control As Trust

Adriel Wenbwo Chan

Hong Konger

Active
Notified 15 Jan 2020
Residence Hong Kong
DOB July 1982
Nature of Control
  • Significant Influence Or Control As Trust

Madam Chan Tan Ching Fen

Ceased 15 Jan 2020

Ceased

Morningside Venture Investments Ltd

Ceased 6 Apr 2016

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

6 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
4 Jun 2026OfficersAppointment of Laura Smith as director
1 Jun 2026IncorporationMemorandum Articles
1 Jun 2026ResolutionResolutions
28 May 2026CapitalAllotment of shares (GBP 133,268.447) on 8 May 2026
21 Apr 2026CapitalAllotment of shares (GBP 100,074.153) on 29 Jan 2026
4 Jun 2026 Officers

Appointment of Laura Smith as director

1 Jun 2026 Incorporation

Memorandum Articles

1 Jun 2026 Resolution

Resolutions

28 May 2026 Capital

Allotment of shares (GBP 133,268.447) on 8 May 2026

21 Apr 2026 Capital

Allotment of shares (GBP 100,074.153) on 29 Jan 2026

Recent Activity

Latest Activity

Appointment of Laura Smith as director

2 days ago on 4 Jun 2026

Memorandum Articles

5 days ago on 1 Jun 2026

Resolutions

5 days ago on 1 Jun 2026

Allotment of shares (GBP 133,268.447) on 8 May 2026

1 weeks ago on 28 May 2026

Allotment of shares (GBP 100,074.153) on 29 Jan 2026

1 months ago on 21 Apr 2026